Abbott, founded in 1944, stands as a venerable leader in the global healthcare sector. With a diverse portfolio that spans diagnostics, medical devices, nutritionals, and branded generic medicines, Abbott operates in more than 160 countries, supported by a workforce exceeding 122,000 professionals.
Positioned primarily within the Biotechnology, Health Care, Manufacturing, Medical Devices, Nutrition, and Pharmaceutical industries, the company's core mission encapsulated in their slogan, "Life-changing health technologies in the area of diagnostics, medical devices, nutritionals and branded generic medicines," highlights its commitment to enhancing global health outcomes.
Headquartered in the United States, Abbott raised its last investment of $100.00K through a Post Ipo Debt transaction on 01 March 2011. Although devoid of recent high-profile investments, the company's expansive reach and proven market presence continue to make it a robust entity in the healthcare landscape.